Brief: Geron Corp Announces Up To $375 Mln In Funding With Royalty Pharma And Pharmakon Advisors
07/11/2024 12:39
Nov 7 (Reuters) - Geron Corp GERN.O :
* GERON CORPORATION ANNOUNCES UP TO $375 MILLION IN FUNDING
WITH
ROYALTY PHARMA AND PHARMAKON ADVISORS
* GERON CORP - RECEIVES $250 MILLION AT CLOSING, $125
MILLION IN
DEBT AVAILABLE
Source text: ID:nBwbVd02ma
Further company coverage: GERN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Geron
See all newsBrief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Geron Corporation reports results for the quarter ended June 30 - Earnings Summary
Geron's Q2 revenue rises on RYTELO growth
Brief: Geron Q2 EPS USD -0.02
Brief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)